Arcturus Therapeutics to Release Clinical Data for the Second Stage of Ornithine Transaminase Deficiency and Update mRNA Liver Treatment Platform
2026-09-18 21:01:48
According to CoinMeta, as reported by Reuters, Arcturus Therapeutics will release clinical data from the second phase of studies on ornithine transaminase (Otc) deficiency and provide updates regarding the mRNA liver treatment platform.
Source:Internet
This content is for market information only and does not constitute investment advice.
Follow WalletJYS official accounts to stay updated

Hot Articles
Refresh

Legit Bitcoin Trading Apps 2026: Top 4 Safe & Regulated Picks
4h ago

Zcash Jumps 23% After Fed Hike, Beats Bitcoin: How Far Can It Go?
09-17 18:03

Which Crypto Wallet Is Best? 2026 Ranking & Review
09-16 18:34

What Is CASHCAT Coin? Why It Leads On-Chain Despite 26% Weekly Drop
09-15 16:04

Top 10 Crypto Trading Apps Sept 2026: Ranking & Review
09-14 17:24



